Northwest Biotherapeutics, Inc. Stock Other OTC
Equities
NWBO
US66737P6007
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 1.68M | Sales 2023 | 1.93M | Capitalization | 822M |
---|---|---|---|---|---|
Net income 2022 | -105M | Net income 2023 | -62M | EV / Sales 2022 | 505 x |
Net Debt 2022 | 19.29M | Net Debt 2023 | 43.43M | EV / Sales 2023 | 448 x |
P/E ratio 2022 |
-7.59
x | P/E ratio 2023 |
-11.7
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.84% |
Latest transcript on Northwest Biotherapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 99-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 96-03-17 |
Linda Powers
CEO | Chief Executive Officer | 68 | 07-05-16 |
Navid Malik
BRD | Director/Board Member | 55 | 12-03-31 |
1st Jan change | Capi. | |
---|---|---|
+20.82% | 127B | |
+21.96% | 116B | |
+23.58% | 27.69B | |
-22.97% | 19.62B | |
-17.08% | 16.26B | |
-19.03% | 15.49B | |
+11.66% | 14.81B | |
-48.41% | 14.39B | |
+54.78% | 14.11B |